Cognition Therapeutics Inc. (CGTX) Live Share Price, Invest From India

Cognition Therapeutics Inc. Stock Performance

as on June 26, 2026 at 2:16 pm IST

Day's Low
Day's High
$0.93
Day's Price Range
$1.22
$1.13
17.70%
Downside
7.96%
Upside
52 Week's Low
52 Week's High
$0.29
52-Week Price Range
$3.83
$1.13
74.04%
Downside
238.94%
Upside

Cognition Therapeutics Inc. share price movements today

Previous Close: $1.02
Open: $1.03
Volume: 4.2M
Day's Low - High: $0.93 - $1.22
52 Week Low - High: $0.29 - $3.83

Cognition Therapeutics Inc. Historical Returns

1 Month Return: -8.87 %
3 Month Return: + 4.63 %
1 Year Return: + 248.23 %
3 Year Return: -59.79 %
5 Year Return: 0 %

Cognition Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Cognition Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$104.7M

EPS (TTM)

-0.3225

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-42.8M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-92.82%

Cognition Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cognition Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Cognition Therapeutics Inc.	BUY	$104.7M	NA	NA	0.00%	NA
Alnylam Pharmaceuticals Inc.	BUY	$39.3B	67.15%	74.07	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$120.6B	147.08%	28.17	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$65.4B	12.64%	15.22	29.65%	0.58%

Stock Returns calculator for Cognition Therapeutics Inc. Stock including INR - Dollar returns

The Cognition Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Cognition Therapeutics Inc. investment value today

Current value as on today

₹3,87,416

Returns

₹2,87,416

(+287.42%)

Returns from Cognition Therapeutics Inc. Stock

₹2,53,125 (+253.13%)

Dollar Impact

₹34,291 (+34.29%)

Analyst Recommendation on Cognition Therapeutics Inc. Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Cognition Therapeutics Inc.. Average target price of $3.5

Cognition Therapeutics Inc. Share Price Target

Get share price movements and forecasts by analysts on Cognition Therapeutics Inc..

What analysts predicted

67.71%UPSIDE

Target Price

$3.5

Current Price

$1.13

Analyzed by

9 Analysts

Target

$3.50

Cognition Therapeutics Inc. target price $3.5, a slight upside of 67.71% compared to current price of $1.13. According to 9 analysts rating.

Indian Investors' Interest in Cognition Therapeutics Inc. Stock

Search interest for Cognition Therapeutics Inc. Stock has increased by 7% in the last 30 days, reflecting an upward trend in search activity.

Time period: May 27, 2026 to June 26, 2026

Change:7% versus previous 30 day period

Cognition Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	0	-	-	-	0	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-15	-14	-14	-14	-10	-13	-13	-6	-13	-8
EBITDA	-8	-9	-6	-9	-7	-8	-6	-4	-3	-4
Interest Expense	0	0	0	0	0	0	0	-	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-8	-9	-7	-9	-7	-8	-6	-4	-3	-4
Income Tax Expense	2	0	-	-	-	-	-	-	-	-
Net Income	-8	-9	-7	-9	-7	-8	-6	-4	-3	-4
Net Profit Margin	-2188.44%	0.00%	0.00%	0.00%	-3136.80%	0.00%	0.00%	0.00%	0.00%	0.00%

Cognition Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0
Operating Income	-17	-17	-28	-43	-50	-53	-47
EBITDA	-3	-5	-10	-21	-25	-33	-23
Interest Expense	1	1	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0
Income Before Tax	-4	-7	-11	-21	-25	-33	-23
Income Tax Expense	2	2	-1	-22	-	-	-
Net Income	-6	-10	-11	0	-25	-33	-23
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Cognition Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-9	-7	-9	-7	-8	-6	-4	-3	-4
Operating Cash Flow	-7	-5	-6	-8	-9	-5	-5	-3	-5
Investing Cash Flow	-	0	-	0	-	-	-	0	-
Financing Cash Flow	11	0	0	11	1	0	33	0	0
Change in Cash	4	-6	-6	2	-8	-4	28	-2	-5

Cognition Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-7	-11	-21	-25	-33	-23
Operating Cash Flow	-3	-3	-18	-16	-28	-24
Investing Cash Flow	0	0	0	0	0	0
Financing Cash Flow	5	53	5	4	23	36
Change in Cash	2	49	-13	-11	-4	11

Global Institutional Holdings in Cognition Therapeutics Inc.

Funds	Holdings
CM Management, LLC	0.45%
Graham Capital Management	0.17%
TANG CAPITAL MANAGEMENT LLC	1.36%
Tocqueville Asset Management L.P.	0.22%
Renaissance Technologies Corp	1.25%

See all

Insights on Cognition Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, CGTX has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECT
Against Peers
In the last 3 years, Cognition Therapeutics, Inc. Common Stock has experienced a drawdown of -59.8%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 38.9%
NEGATIVE IMPACT
Price Dip
In the last 7 days, CGTX stock has moved down by -22.1%

About Cognition Therapeutics Inc.

Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is zervimesine, an orally delivered small molecule to protect neuronal synapses by preventing the binding of oligomers of pathogenic proteins, which is in Phase 2 clinical studies for the treatment of Alzheimer's disease and Mild Cognitive Impairment, as well as geographic atrophy secondary to dry age-related macular degeneration and dementia with Lewy bodies. Cognition Therapeutics, Inc. was incorporated in 2007 and is based in Purchase, New York.

Organisation	Cognition Therapeutics Inc.
Headquarters	2500 Westchester Ave., Purchase, NY, United States, 10577
Industry	Biotechnology
CEO	Ms. Lisa Ricciardi
E-voting on shares	Click here to vote

Key Management of Cognition Therapeutics Inc.

Name	Title
Dr. Steven A. Weissman Ph.D.	VP & Head of CMC
Ms. Anita Cornet	Head of Quality
Mr. Bobby Horn	Corporate Controller
Ms. Lisa Ricciardi	CEO, President & Director
Mr. John Brendan Doyle	Chief Financial Officer
Dr. Anthony O. Caggiano M.D., Ph.D.	Chief Medical Officer

FAQs

What is Cognition Therapeutics Inc. share price today?

Cognition Therapeutics Inc. share price today is $1.13 as on June 26, 2026 at 8:46 am IST at the close of the market. Cognition Therapeutics Inc. share today touched a day high of $1.22 and a low of $0.93.

What is the 52 week high and 52 week low for Cognition Therapeutics Inc. share?

Cognition Therapeutics Inc. share touched a 52 week high of $3.83 on August 25, 2025 and a 52 week low of $0.29 on July 1, 2025. Cognition Therapeutics Inc. stock price today i.e. June 26, 2026 at 8:46 am IST is closed at $1.13,which is 70.50% down from its 52 week high and 285.27% up from its 52 week low.

What is Cognition Therapeutics Inc.'s market capitalisation today?

Cognition Therapeutics Inc. market capitalisation is $0.00T as on June 26, 2026 at 8:46 am IST.

How to invest in Cognition Therapeutics Inc. Stock (CGTX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cognition Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cognition Therapeutics Inc. Shares that will get you 1.3274 shares as per Cognition Therapeutics Inc. share price of $1.13 per share as on June 26, 2026 at 8:46 am IST.

What is the minimum amount required to buy Cognition Therapeutics Inc. Stock (CGTX) from India?

Indian investors can start investing in Cognition Therapeutics Inc. (CGTX) shares with as little as ₹94.395 or $1 (as of June 26, 2026 at 2:40 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹943.95 in Cognition Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on June 26, 2026 at 2:40 pm IST). Based on Cognition Therapeutics Inc. share’s latest price of $1.13 as on June 26, 2026 at 8:46 am IST, you will get 8.8496 shares of Cognition Therapeutics Inc.. Learn more about fractional shares .